Topical dorzolamide increases pericentral visual function in age-related maculopathy: Pilot study findings with short-wavelength automated perimetry

Acta Ophthalmologica Scandinavica

Volumn 83, Issue 2, 2005, Pages 154-160

  Remky, Andreas ^a,c   Weber, Anke ^a   Arend, Oliver ^a   Sponsel, William Eric ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Age related macular degeneration; Age related maculopathy; Perimetry; Visual field

Indexed keywords

ARTIFICIAL TEAR; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED PERIMETRY; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LIQUIFILM; MALE; PERIMETER; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; SAMPLE SIZE; SENSITIVITY AND SENSIBILITY; STATISTICAL ANALYSIS; VISION TEST; VISUAL ACUITY; VISUAL SYSTEM FUNCTION; VISUAL SYSTEM PARAMETERS;

ADMINISTRATION, TOPICAL; AGED; CARBONIC ANHYDRASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; PERIMETRY; PILOT PROJECTS; PROSPECTIVE STUDIES; SULFONAMIDES; THIOPHENES; VISUAL ACUITY; VISUAL FIELDS;

EID: 17644370649     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2005.00406.x     Document Type: Article

References (72)

1. Alberti E, Hoyer S, Hamer J, Stoeckel H, Packschiess P & Weinhardt F (1975): The effect of carbon dioxide on cerebral blood flow and cerebral metabolism in dogs. Br J Anaesthesiol 47: 941-947.
2. Alm A & Bill A (1972): The oxygen supply to the retina. II. Effects of high intraocular pressure and of increased arterial carbon dioxide tension on uveal and retinal blood flow in cats: a study with labelled microspheres including flow determinations in brain and some other tissues. Acta Physiol Scand 84: 306-319.
3. Anderson B (1968): Ocular effects of changes in oxygen and carbon dioxide tension. Trans Am Ophthalmol Soc 66: 424-474.
4. AREDS (2001): A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene and zinc for age-related macular degeneration and vision loss. AREDS Report No. 8. Arch Ophthalmol 119: 1417-1436.
5. Arend O, Harris A, Wolter P & Remky A (2003): Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol and latanoprost in newly diagnosed open-angle glaucoma patients. Acta Ophthalmol 81: 474-479.
6. Bengtsson B & Heijl A (2003): Perimetric learning with SWAP and WWP. Ophthalmic Res 35: 65.
7. Bill A (1962): Aspects of physiological and pharmacological regulation of uveal blood flow. Acta Soc Med Upsalien 67: 122-134.
8. Bressler NM, Bressler SB, Seddon JM, Gragoudas ES & Jacobson LP (1988): Drusen characteristics in patients with exudative versus non-exudative age-related macular degeneration. Retina 8: 109-114.
9. Chen S-J, Cheng C-Y, Lee A-F, Lee F-L, Chou JCK, Hsu W-M & Liu J-H (2001): Pulsatile ocular blood flow in asymmetric exudative age-related macular degeneration. Br J Ophthalmol 85: 1411-1415.
10. Chen JC, Fitzke FW, Pauleikhoff D & Bird AC (1992): Functional loss in age-related Bruch's membrane change with choroidal perfusion defect. Invest Ophthalmol Vis Sci 33: 334-340.
11. Ciulla T, Harris A, Chung HS, Danis RP, Kagemann L, McNulty L, Pratt LM & Martin BJ (1999): Colour Doppler imaging discloses reduced ocular blood flow velocities in non-exudative age-related macular degeneration. Am J Ophthalmol 128: 75-80.
12. Ciulla TA, Harris A, Kagemann L, Danis RP, Pratt LM, Chung HS, Weinberger D & Garzozi HJ (2002): Choroidal perfusion perturbations in non-neovascular age-related macular degeneration. Br J Ophthalmol 86: 209-213.
13. Crognale MA, Rabin J, Switkes E & Adams AJ (1993): Selective loss of S-pathway sensitivity in central serous choroidopathy revealed by spatio-chromatic visual evoked cortical potential (VECP). In: Cavonius CR, (ed). Colour Vision Deficiencies XI. B. Drum: Kluwer Academic Publishers. 229-239.
14. Eisner A, Klein ML, Zilis JD & Watkins MD (1992): Visual function and the subsequent development of exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 33: 3091-3102.
15. Friedman E (1997): A haemodynamic model of the pathogenesis of age-related macular degeneration. [Editorial.] Am J Ophthalmol 124 677-682.
16. Friedman E & Chandra SR (1965): Choroidal blood flow. III. Effects of oxygen and carbon dioxide. Arch Ophthalmol 73: 70-71.
17. Friedman E, Krupsky S, Lane AM, Oak SS, Friedman ES, Egan K & Gragoudas ES (1995): Ocular blood flow velocity in age-related macular degeneration. Ophthalmology 102: 640-646.
18. Gibbs FA, Gibbs EL & Lennox WG (1943): The value of carbon dioxide in counteracting the effects of low oxygen. Aviat Med 14: 250-261.
19. Gotoh F, Meyer JS & Tomita M (1966): Carbonic anhydrase inhibition and cerebral venous blood gases and ions in man. Arch Intern Med 117: 39-46.
20. Greenstein VC, Shapiro A, Zaidi Q & Hood DC (1992): Psychophysical evidence for post-receptor sensitivity loss in diabetics. Invest Ophthalmol Vis Sci 33: 2781-2790.
21. Grover S, Fishman GA, Fiscella RG & Adelman AE (1997): Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular oedema in patients with retinitis pigmentosa. Retina 17: 222-231.
22. Grunwald J, Hariprasad SM, DuPont J, Maguire MG, Fine SL, Brucker AJ, Maguire AM & Ho AC (1998): Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci 39: 385-390.
23. Harris A, Arend O, Arend S & Martin B (1996): Effects of topical dorzolamide on retinal and retrobulbar haemodynamics. Acta Ophthalmol Scand 74: 569-572.
24. Harris A, Arend O, Kagemann L, Garret M, Chung HS & Martin B (1999): Dorzolamide, visual function and ocular haemodynamics in normal tension glaucoma. J Ocul Pharmacol Ther 15: 189-197.
25. Harris A, Ciulla TA, Pratt LM, Rechtman E, Kagemann L, Piper HC & Garzosi HJ (2003): The effects of dorzolamide on choroidal and retinal perfusion in non-exudative age-related macular degeneration. Br J Ophthalmol 87: 753-757.
26. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B & Hussein M (2002): Early Manifest Glaucoma Trial: reduction of intraocular pressure and glaucoma progression. Arch Ophthalmol 120: 1268-1279.
27. Hudson C, Flanagan JG, Turner GS, Chen HC, Young LB & McLeod D (1998): Short-wavelength sensitive visual field loss in patients with clinically significant diabetic macular oedema. Diabetologia 41: 918-928.
28. International ARM Epidemiological Study Group (1995): An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 39 367-374.
29. Johnson CA, Adams AJ, Casson EJ & Brandt JD (1993a): Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss. Arch Ophthalmol 111: 645-650.
30. Johnson CA, Adams AJ, Casson EJ & Brandt JD (1993b): Progression of early glaucomatous visual field loss as detected by blue-on-yellow and standard white-on-white automated perimetry. Arch Ophthalmol 111: 651-656.
31. Johnson CA, Adams AJ, Twelker JD & Quigg JM (1988): Age-related changes in the central visual field for short-wavelength-sensitive pathways. J Opt Soc Am A 5: 2131-2139.
32. Johnson CA, Brandt JD, Khong AM & Adams AJ (1995): Short-wavelength automated perimetry in low-, medium- and high-risk ocular hypertensive eyes. Arch Ophthalmol 113: 70-76.
33. Kennedy JA, Karl AA & Kirkland JS (1978): Cerebral blood flow autoregulation: effect of hypercapnia on cerebral tissue gas concentrations. J Surg Res 24: 150-153.
34. Kety SS & Schmidt CF (1948): Effects of altered arterial tensions of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen consumption of normal young men. J Clin Invest 27: 484-492.
35. Klein R, Davis MD, Magli YL, Segal P, Klein BE & Hubbard L (1991): The Wisconsin age-related maculopathy grading system. Ophthalmology 98: 1128-1134.
36. Kruger A, Matulla B, Wolzt M, Pieh S, Strenn K, Findl O, Eichler H & Schmetterer L (1998): Short-term oral pentoxifylline use increases choroidal blood flow in patients with age-related macular degeneration. Arch Ophthalmol 116: 27-30.
37. Krumpaszky HG & Klauss V (1996): Epidemiology of blindness and eye disease. Ophthalmologica 210: 1-84.
38. Kwon YH, Park HJ, Jap A, Ugurlu S & Caprioli J (1998): Test-retest variability of blue-on-yellow perimetry is greater than white-on-white perimetry in normal subjects. Am J Ophthalmol 126: 29-36.
39. Leibowitz H, Kruger DE, Maunder LR et al. (1980): The Framingham Eye Study Monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration and visual acuity in a general population of 2631 adults, 1973-75. Surv Ophthalmol 24: 335-610.
40. Leske MC, Heijl A, Hyman L & Bengtsson B (1999): Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 106 2144-2153.
41. Macular Photocoagulation Study Group (1994): Laser photocoagulation for juxtafoveal choroidal neovascularization. Arch Ophthalmol 112: 500-509.
42. Marré M & Marré E (1986): Erworbene Störungen des Farbensehens: Diagnostik. Stuttgart: Gustav Fischer Verlag.
43. Martinez A, Gonzalez F, Capeans C & Perez R & Sanchez-Salorio M (1999): Dorzolamide effect on ocular blood flow. Invest Ophthalmol Vis Sci 40: 1270-1275.
44. Mori F, Konno S, Hikichi T, Yamaguchi Y, Ishiko S & Yoshida A (2001): Pulsatile ocular blood flow study: decreases in exudative age-related macular degeneration. Br J Ophthalmol 85: 531-533.
45. Normenausschuss Feinmechanik & Optik (1990): DIN 58220 (1974-90). B1 3: Sehschärfenbestimmung. Teil 1: (1988) Normsehzeichen. Teil 2: Anschluss von Sehzeichen. Teil 3: (1990) Prüfung für Gutachten. Teil 4: Nahvisusbestimmung. Teil 5: (1986) Allgemeine Sehtestung. Teil 6: Strassenverkehrsbezogener Sehtest. Deutsch Institut für Normung e. V. Beuth.
46. Pauleikhoff D, Harper CA, Marshall J & Bird AC (1990): Ageing changes in Bruch's membrane. Ophthalmology 97: 171-178.
47. Pauleikhoff D, Spital G, Radermacher M, Brumm GA, Lommatsch A & Bird AC (1999): A fluorescein indocyanine green angiographic study of choriocapillaris in age-related macular disease. Arch Ophthalmol 117 1353-1358.
48. Piguet B, Palmwang IB, Chrisholm IH, Minassian D & Bird AC (1992): Evolution of age-related macular degeneration with choroidal perfusion abnormality. Am J Ophthalmol 113: 657-663.
49. Remky A & Arend O (2000): Intraindividuelle Variabilität der Blau/Gelb-Perimetrie. Ophthalmologe 97: 774-780.
50. Remky A, Arend O & Hendricks S (2000): Short-wavelength automated perimetry and capillary density in early diabetic maculopathy. Invest Ophthalmol Vis Sci 41: 274-282.
51. Remky A, Lichtenberg K, Elsner AE & Arend O (2001): Short-wavelength automated perimetry in age-related maculopathy. Br J Ophthalmol 85: 1432-1426.
52. Remky A, Lichtenberg K, Weber A, Plange N, Elsner AE & Arend O (2003b): Short-wavelength automated perimetry in age-related maculopathy: correlation with the visual outcome. Invest Ophthalmol Vis Sci 44: E-Abstract 1743.
53. Remky A, Weber A, Hendricks S, Lichtenberg K & Arend O (2003a): Short-wavelength automated perimetry in patients with diabetes mellitus without macular oedema. Graefes Arch Clin Exp Ophthalmol 241 468-471.
54. Ross RD, Barofsky JM, Cohen G, Baber WB, Palao SW & Gitter KA (1998): Presumed macular choroidal watershed vascular filling, choroidal neovascularization, and systemic vascular disease in patients with age-related macular degeneration. Am J Ophthalmol 125: 71-80.
55. Sample PA, Martinez GA & Weinreb RN (1994): Short-wavelength automated perimetry without lens density testing. Am J Ophthalmol 118 632-641.
56. Sample PA & Weinreb RN (1990): Colour perimetry for assessment of primary open-angle glaucoma. Invest Ophthalmol Vis Sci 31: 1869-1875.
57. Siik S, Chylack LT, Friend J, Wolfe J, Teikari J, Nieminen H & Airaksinen IJ (1999): Lens autofluorescence and light scatter in relation to the lens opacities classification systems, LOCS III. Acta Ophthalmol Scand 77: 509-514.
58. Som A, Russell SR & Bassi CJ (1995): Short-wavelength automated perimetry in early age-related macular degeneration. Invest Ophthalmol Vis Sci 36: 233.
59. Sponsel WE (1999): Topical Anhydrase Inhibitors and Visual Function: Association with Retinal Circulation and Intraocular Pressure in Normal Eyes. Current Concepts on Ocular Blood Flow in Glaucoma. The Hague: Kugler. 251-265.
60. Sponsel WE, DePaul KL & Zetlan SR (1992): Retinal haemodynamic effects of carbon dioxide, hyperoxia and mild hypoxia. Invest Ophthalmol Vis Sci 33: 1864-1869.
61. Sponsel WE, Harrison J, Elliott WR, Trigo Y, Kavanagh J & Harris A (1997): Dorzolamide hydrochloride and visual function in normal eyes. Am J Ophthalmol 123: 759-766.
62. Stur M, Tittl M, Reitner A & Meisinger V (1996): Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci 37: 1225-1235.
63. Sugrue MF (2000): Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Prog Ret Eye Res 19: 87-112.
64. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999): Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of two randomized clinical trials. TAP Report. Arch Ophthalmol 117: 1329-1345.
65. Trokel S (1965): Effect of respiratory gases upon choroidal haemodynamics. Arch Ophthalmol 73: 838-842.
66. 2 on inner-retinal oxygen availability in monkeys. Invest Ophthalmol 12: 449-455.
67. Vingerling JR, Dielemans I, Holman A, Grobbee D, Hijmering M, Kramer CF & de Jong PT (1995): The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102: 205-210.
68. Weber A, Remky A, Cordes A & Arend O (2003): Short-wavelength automated perimetry (SWAP) and retrobulbar haemodynamics in age-related maculopathy. Invest Ophthalmol Vis Sci 44: E-Abstract 5016.
69. Widder RA, Brunner R, Lüke C, Godehardt E, Heimann K & Borberg H (1999): Influence of membrane differential filtration on the natural course of age-related macular degeneration (AMD). Final results of a randomized trial. Invest Ophthalmol Vis Sci 40: 377.
70. Wild JM, Cubbidge RP, Pacey IE & Robinson R (1998): Statistical aspects of the normal visual field in short-wavelength automated perimetry. Invest Ophthalmol Vis Sci 39: 54-63.
71. Yang S & Krasney JA (1995): Cerebral blood flow and metabolic responses to sustained hypercapnia in awake sheep. J Cerebral Blood Flow Metab 15: 115-123.
72. Zhao J, Sastry SM, Sperduto RD, Chew EY, Remaley NA & the Eye Disease Case-Control Study Group (1993): Arteriovenous crossing patterns in branch retinal vein occlusion. Ophthalmology 100: 423-428.